NHS England has announced the award of new contracts for stereotactic radiosurgery and radiotherapy (SRS/SRT) – specialist forms of radiotherapy that can be used to treat patients with intracranial conditions, such as benign and malignant brain tumours.
More than 6,200 patients a year are expected to benefit from these services by 2018/9, compared to just over 2,400 in 2014/15. The new SRS/SRT services are spread across all regions of England, improving access to services and making it possible to treat more people closer to home.
The University College London Hospitals Foundation Trust (UCLH) has successfully secured the contracts to provide services as the Supra Centre for the South of England, serving a population of some 31.3m, thus becoming the only centre in England designated to receive referrals for all commissioned indications whatever the age of the patient. The service will be delivered by a partnership between UCLH and QSRC Ltd that derives a significant number of strengths from the well established integration between UCLH’s diverse and many areas of expertise and the experience of QSRC Ltd in operating a Gamma Knife Centre. UCLH also has an arrangement with Great Ormond Street (GOSH) for paediatric patients.
Lynne Brooks, QSRC Director said “We are very pleased that NHSE is increasing access to these advanced forms of radiotherapy which we have long championed and proud to be working closely with UCLH. QSRC Ltd will play an important part as a sub-contractor operating the Gamma Knife Centre and delivering a patient focused service. Together with UCLH we look forward to building upon the relationships with referral centres across the South of England, developing new patient pathways and providing a service which offers significant advantages to patients”.
You can view the full NHS England press release here.